August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
David Steensma: Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances
Nov 12, 2023, 17:42

David Steensma: Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances

David Steensma, Chief Medical Officer of Ajax Therapeutics, posted on X/Twitter.

“Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances led by Janghee Woo (now Winship Cancer Institute of Emory). Clonal hematopoiesis was associated with incident anemia and markers of inflammation which were attenuated by IL-1b inhibitor therapy.”

Source: David Steensma/X